Karp Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
RJFSA
BFG
RJA
Karp Capital Management's FBT Position: Q1 2022 in Review
Karp Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2022, closing a stake of 74,930 shares — an estimated $12.1M sold.
Karp Capital Management first reported a position in FBT in Q2 2018 and held it in 14 quarters. The position peaked at $12.1M in Q4 2021. 220 funds tracked by Wall St. Rank hold FBT as of Q1 2022.
- Karp Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2022 after selling out during the quarter.
- Karp Capital Management sold 74,930 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2022, an estimated $12.1M.
- Karp Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and held it in 14 quarters.
- Karp Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $12.1M in Q4 2021.
- 220 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2022.
Based on Karp Capital Management's 13F filing for Q1 2022, filed 11 Apr 2022.